EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Loss of WT1 Drives Adaptive Plasticity in CCDC6-RET Selpercatinib-Resistant Papillary Thyroid Cancer

Giuseppe Siragusa iD, Laura Tomasello iD, Mattia Biondo iD, Fabiola Vaglica, Carla Giordano iD, Giorgio Arnaldi iD, Giuseppe Pizzolanti iD

Current Issues in Molecular Biology · 04.03.2026 · 48 (3) · 274

DOI: 10.3390/cimb48030274 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Issues in Molecular Biology, online erschienen am 04.03.2026. Verfasst von Giuseppe Siragusa und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological, Chemical and Pharmaceutical Sciences and Technologies (STEBICEF), University of Palermo, 90128 Palermo, PA, Italy. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MIUR under PNRR M4C2I1.3 Samothrace, Sicilian Micro and Nanon Technology Research and Innovation Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Papillary Thyroid Cancer (PTC) harboring CCDC6-RET translocation is typically classified as a differentiated epithelial tumor. Although Selpercatinib, a RET-selective drug, was recently approved for use in advanced PTC, the emergence of drug resistance has already been observed. Tumor plasticity, including non-canonical Epithelial–Mesenchymal Transition (EMT) programs, is recognized as a key mechanism underlying drug resistance. The downregulation of the transcription factor Wilms’ Tumor 1 (WT1) in cancer is associated with increased motility, invasiveness, and metastatic potential.

Methods

In this study, we developed a selpercatinib-resistant PTC-derived cell line, TPC-1-SelpR. Bioinformatic analyses were conducted to study the promoter of the CCDC6-RET gene and the transcriptomic landscape of PTC from RNAseq data. Subsequent real-time PCR, Western blot, and imaging techniques, such as confocal microscopy (CM) and fluorescence microscopy (FM), were employed to study the effects of WT1 loss-of-function following RNAi silencing.

Results

In TPC-1-SelpR, WT1 expression appears downregulated compared to its counterpart, TPC-1. Crucially, WT1 silencing induced a context-dependent modulation of the CCDC6-RET driver: while WT1 silencing reduced CCDC6-RET expression in TPC-1, in TPC-1-SelpR, a post-transcriptional compensation of CCDC6-RET was observed. The gene expression of several factors involved in EMT, such as Twist, Vimentin, Integrin beta-1, and Profilin, was rewired in TPC-1-SelpRWT1-knockdown. Although the Vimentin protein product decreased, CM and FM analyses confirmed a reorganization of residual protein: the subcellular redistribution was more dispersed in TPC-1-SelpRWT1-knockdown. Further upregulation of the stemness factor Sox2 over the differentiation factor Sox17 occurred. These molecular changes were associated with higher cell motility of TPC-1-SelpRWT1-knockdown.

Conclusions

Collectively, these findings suggest that WT1 is a critical regulator involved in tumor plasticity, thereby supporting selpercatinib resistance.

Schlagwörter

Stichwörter der Autor:innen

CCDC6-RETWT1cancerresistanceselpercatinibthyroid

Autor:innen und Institutionen

  • Department of Biological, Chemical and Pharmaceutical Sciences and Technologies (STEBICEF), University of Palermo, 90128 Palermo, PA, Italy.
  • Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, 90127 Palermo, PA, Italy.
  • Advanced Technologies Network Center (ATEN Center), University of Palermo, 90128 Palermo, PA, Italy.

ORCID-Profile: Giuseppe Siragusa, Laura Tomasello, Mattia Biondo, Carla Giordano, Giorgio Arnaldi, Giuseppe Pizzolanti

Förderung

  • MIUR under PNRR M4C2I1.3 Samothrace, Sicilian Micro and Nanon Technology Research and Innovation Center

Zitieren

APA

Siragusa, G., Tomasello, L., Biondo, M., Vaglica, F., Giordano, C., Arnaldi, G., & Pizzolanti, G. (2026). Loss of WT1 Drives Adaptive Plasticity in CCDC6-RET Selpercatinib-Resistant Papillary Thyroid Cancer. Current Issues in Molecular Biology, 48(3), 274. https://doi.org/10.3390/cimb48030274

Vancouver

Siragusa G, Tomasello L, Biondo M, Vaglica F, Giordano C, Arnaldi G, et al. Loss of WT1 Drives Adaptive Plasticity in CCDC6-RET Selpercatinib-Resistant Papillary Thyroid Cancer. Current Issues in Molecular Biology. 2026;48(3):274. doi:10.3390/cimb48030274

BibTeX
@article{Siragusa2026,
  author = {Siragusa, Giuseppe and Tomasello, Laura and Biondo, Mattia and Vaglica, Fabiola and Giordano, Carla and Arnaldi, Giorgio and Pizzolanti, Giuseppe},
  title = {Loss of WT1 Drives Adaptive Plasticity in CCDC6-RET Selpercatinib-Resistant Papillary Thyroid Cancer},
  journal = {Current Issues in Molecular Biology},
  year = {2026},
  volume = {48},
  number = {3},
  pages = {274},
  doi = {10.3390/cimb48030274}
}
Kostenlos starten →